Lingmei Li

832 total citations
38 papers, 613 citations indexed

About

Lingmei Li is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lingmei Li has authored 38 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lingmei Li's work include Glycosylation and Glycoproteins Research (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Ferroptosis and cancer prognosis (3 papers). Lingmei Li is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Ferroptosis and cancer prognosis (3 papers). Lingmei Li collaborates with scholars based in China, United States and Canada. Lingmei Li's co-authors include Wenfeng Cao, Lisha Qi, Yalei Wang, Wangzhao Song, Bin Zhang, Baocun Sun, Lu Cao, Zhongfu Wang, Chengjian Wang and Zhi-Jie Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Lingmei Li

35 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingmei Li China 15 385 90 87 79 61 38 613
Rishi K. Gara India 12 323 0.8× 84 0.9× 98 1.1× 35 0.4× 30 0.5× 12 594
Chunyu Li China 19 533 1.4× 265 2.9× 96 1.1× 68 0.9× 65 1.1× 37 811
Chi-Chung Wang Taiwan 11 417 1.1× 156 1.7× 132 1.5× 80 1.0× 21 0.3× 12 889
Bo-Yeon Kim South Korea 15 388 1.0× 134 1.5× 96 1.1× 30 0.4× 31 0.5× 22 627
Ida Aronchik United States 18 670 1.7× 68 0.8× 155 1.8× 34 0.4× 27 0.4× 31 981
Yuyin Li China 21 617 1.6× 119 1.3× 284 3.3× 55 0.7× 32 0.5× 50 984
Shota Moriya Japan 17 415 1.1× 50 0.6× 129 1.5× 90 1.1× 15 0.2× 30 718
Chunfang Liu China 16 549 1.4× 73 0.8× 141 1.6× 89 1.1× 53 0.9× 36 827
Qi Huang China 16 287 0.7× 100 1.1× 124 1.4× 53 0.7× 16 0.3× 47 572
Jeonghun Han South Korea 17 337 0.9× 112 1.2× 207 2.4× 81 1.0× 15 0.2× 28 831

Countries citing papers authored by Lingmei Li

Since Specialization
Citations

This map shows the geographic impact of Lingmei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingmei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingmei Li more than expected).

Fields of papers citing papers by Lingmei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingmei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingmei Li. The network helps show where Lingmei Li may publish in the future.

Co-authorship network of co-authors of Lingmei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lingmei Li. A scholar is included among the top collaborators of Lingmei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingmei Li. Lingmei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Xiaoying, Lingmei Li, Jiacheng Wu, et al.. (2025). Recent progress in antimicrobial activity, mechanism, and application of polyoxometalate and its hybrid composites. Rare Metals. 44(11). 8292–8328.
2.
Li, Lingmei, Hao Guo, Lin Li, et al.. (2025). Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome. BMC Complementary Medicine and Therapies. 25(1). 9–9. 1 indexed citations
3.
Li, Lingmei, et al.. (2024). Tumor microenvironment‐responsive drug self‐delivery systems to treat cancer and overcome MDR. Rare Metals. 44(1). 1–33. 1 indexed citations
4.
Han, Xiao, Lingmei Li, Hongxu Meng, et al.. (2024). Shuangshen ningxin formula attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial function. Journal of Ethnopharmacology. 323. 117690–117690. 18 indexed citations
5.
Han, Xiao, Yehao Zhang, Yuanyuan Chen, et al.. (2024). Hydroxysafflor Yellow A Inhibits Pyroptosis and Protecting HUVECs from OGD/R via NLRP3/Caspase-1/GSDMD Pathway. Chinese Journal of Integrative Medicine. 30(11). 1027–1034. 5 indexed citations
6.
7.
Huang, Jing, Xin‐shang Wang, Tian Gao, et al.. (2023). Astrocyte KDM4A mediates chemokines and drives neutrophil infiltration to aggravate cerebral ischemia and reperfusion injury. Journal of Cerebral Blood Flow & Metabolism. 44(4). 491–507. 9 indexed citations
8.
Chen, Yuanyuan, Lingmei Li, Zixin Liu, et al.. (2023). Shuangshen Ningxin capsule alleviates myocardial ischemia–reperfusion injury in miniature pigs by modulating mitophagy: network pharmacology and experiments in vivo. Chinese Medicine. 18(1). 120–120. 11 indexed citations
9.
Zhang, Wenshuai, Danyang Ren, Yalei Wang, et al.. (2023). ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma. Journal of Translational Medicine. 21(1). 341–341. 25 indexed citations
10.
11.
Li, Lingmei, et al.. (2022). Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. Frontiers in Genetics. 13. 962870–962870. 2 indexed citations
12.
Cao, Lu, et al.. (2022). Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis. Breast Cancer Research and Treatment. 197(1). 71–82. 3 indexed citations
13.
Chen, Ye, Jingxiao Zhang, Yifan He, et al.. (2022). Widely targeted metabolomics reveals stamen petaloid tissue of Paeonia lactiflora Pall. being a potential pharmacological resource. PLoS ONE. 17(9). e0274013–e0274013. 1 indexed citations
14.
Zhao, Yuwei, Lingmei Li, Xiao Han, et al.. (2021). Mechanism of ‘Invigorating Qi and Promoting Blood Circulation’ Drug Pair Ginseng-Danshen on Treatment of Ischemic Heart Disease Based on Network Pharmacology. Chinese Journal of Integrative Medicine. 27(6). 440–445. 10 indexed citations
15.
Zhang, Wenshuai, Lisha Qi, Lu Cao, et al.. (2020). ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression. Cell Death and Disease. 11(7). 511–511. 21 indexed citations
16.
Li, Lijuan, et al.. (2019). Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biology and Medicine. 16(1). 139–139. 19 indexed citations
17.
Liu, Changxu, Jie Li, Li Wei, et al.. (2018). Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor. Cancer Biology and Medicine. 15(4). 461–461.
18.
Cao, Lu, Lisha Qi, Lin Zhang, et al.. (2017). Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma. Cancer Letters. 403. 246–259. 40 indexed citations
19.
Liu, Yang, Yunfeng Li, Lingmei Li, et al.. (2017). Attenuation of Sulfur Dioxide Damage to Wheat Seedlings by Co-exposure to Nitric Oxide. Bulletin of Environmental Contamination and Toxicology. 99(1). 146–151. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rishi K. Gara Breakdown of academic impact, for papers by Chunyu Li Breakdown of academic impact, for papers by Chi-Chung Wang Breakdown of academic impact, for papers by Bo-Yeon Kim Breakdown of academic impact, for papers by Ida Aronchik Breakdown of academic impact, for papers by Yuyin Li Breakdown of academic impact, for papers by Shota Moriya Breakdown of academic impact, for papers by Chunfang Liu Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Jeonghun Han
Rankless by CCL
2026